Choose a country below to begin
- Fast track procedure
- Biological Products Reliance Pathway (decree 343/2021)
- Emergency Use Application & Approval (EUA) - Medicinal Products
- Emergency Use Application & Approval (EUA) - Biological Products
- Reliance pathway for post-approval changes to a registered biotherapeutic product
- EDA-SAHPRA Work Sharing Initiative (WSI) for Registration of Medical Products (Pilot Phase)
- Lot Release of Biological Products in Egypt
- Procedures of Registering Imported and Local Medical Devices holding International Quality Certificates
- Biological Products Reliance Pathway (decree 343/2021)
- Emergency Use Application & Approval (EUA) - Medicinal Products
- Emergency Use Application & Approval (EUA) - Biological Products
- Reliance pathway for post-approval changes to a registered biotherapeutic product
- EDA-SAHPRA Work Sharing Initiative (WSI) for Registration of Medical Products (Pilot Phase)
- Lot Release of Biological Products in Egypt
- Procedures of Registering Imported and Local Medical Devices holding International Quality Certificates
- Fast track for locally manufactured and priority medicines
- Reliance for Regulatory Decision Making in Kenya
- Emergency Use Application (EUA)
- PPB Fast Track, Reliance and Emergency Use Pathways for IVDs Region: AFRICA
- Class B Medical Device Abridged Evaluation Route
- Expedited Class B Registration (EBR) Evaluation Route
- Immediate Class B Registration (IBR) Evaluation Route
- Class C, D and IVDs - Abridged Evaluation Route
- Expedited Class C Registration (ECR)
- Expedited Class D Registration (EDR)
- Reliance for Regulatory Decision Making in Kenya
- Emergency Use Application (EUA)
- PPB Fast Track, Reliance and Emergency Use Pathways for IVDs Region: AFRICA
- Class B Medical Device Abridged Evaluation Route
- Expedited Class B Registration (EBR) Evaluation Route
- Immediate Class B Registration (IBR) Evaluation Route
- Class C, D and IVDs - Abridged Evaluation Route
- Expedited Class C Registration (ECR)
- Expedited Class D Registration (EDR)
- Registration of Imported Drugs in Nigeria
- Licensing or Access to COVID-19 Vaccines
- NAFDAC Medical Devices, Including In-Vitro Diagnostics (IVD) Draft Regulation 2025
- NAFDAC Emergency Use and Expedited Approval Pathway for COVID‑19 IVDs and Related Devices
- Registration of medical devices including in-vitro diagnostics under WHO Collaborative Registration Procedure (CRP)
- Licensing or Access to COVID-19 Vaccines
- NAFDAC Medical Devices, Including In-Vitro Diagnostics (IVD) Draft Regulation 2025
- NAFDAC Emergency Use and Expedited Approval Pathway for COVID‑19 IVDs and Related Devices
- Registration of medical devices including in-vitro diagnostics under WHO Collaborative Registration Procedure (CRP)
- Reliance-based Evaluation Pathways – ABRIDGED REVIEW
- Reliance-based Evaluation Pathways - RECOGNITION
- Reliance-based Evaluation Pathways – VERIFIED REVIEW
- Registration of Candidate COVID-19 vaccines
- EDA-SAHPRA Work Sharing Initiative (WSI) for Registration of Medical Products (Pilot Phase)
- Reliance Review Process - Abridged Review
- Reliance Review Process - Recognition
- Reliance Review Process - Work sharing / Joint assessment
- Reliance Review Process - Verification Review
- Reliance-based Evaluation Pathways - RECOGNITION
- Reliance-based Evaluation Pathways – VERIFIED REVIEW
- Registration of Candidate COVID-19 vaccines
- EDA-SAHPRA Work Sharing Initiative (WSI) for Registration of Medical Products (Pilot Phase)
- Reliance Review Process - Abridged Review
- Reliance Review Process - Recognition
- Reliance Review Process - Work sharing / Joint assessment
- Reliance Review Process - Verification Review